Contact this trialFirst, we need to learn more about you.
Virus Therapy
HIV Vaccine + Adjuvant for HIV Prevention
Recruiting1 awardPhase 1
Philadelphia, Pennsylvania
This trial will evaluate the safety & immunogenicity of an HIV vaccine in adults w/o HIV & in good health, to identify a safe & tolerable dose, route, & schedule of the novel adjuvant. It will also measure the induction of BG18-class immunoglobulin G responses in memory B cells.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.